Header cover image

New Zealand Pharmaceuticals & Biotech Small Cap High Growth Stocks

UPDATED Jul 23, 2022

Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.

2 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
AFTAFT PharmaceuticalsNZ$3.996.7%-11.3%NZ$418.4mNZ$4.40PE21.1xE13.0%n/a
PEBPacific EdgeNZ$0.8418.3%-32.3%NZ$680.6mn/aPS51.8xE4.3%n/a
Page 1 of 1